Sebastian sends us a message
Led Zeppelin, Pink Floyd, Queen. Their songs serve as a soundtrack to Sebastian’s life. A happy 15-year-old kid with a strong, positive attitude, he’s always looking for ways to learn new things and to help others.
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases. The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.